Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Laure Y. Juompan"'
Autor:
Cate Speake, Robert Morrison, Stasya Zarling, Vlad Malkov, Alexander Pichugin, Sharon Wong-Madden, Neta Milman, Urszula Krzych, Zachary W. MacMillen, Jason P. Wendler, Laure Y. Juompan, Stefan H. I. Kappe, Valentino Garcia, Andrew S. Ishizuka, Tejram Sahu, Ying Pei, Charles Anderson, Patrick E. Duffy
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159449 (2016)
PLoS ONE
PLoS ONE
Malaria vaccine development has been hampered by the limited availability of antigens identified through conventional discovery approaches, and improvements are needed to enhance the efficacy of the leading vaccine candidate RTS,S that targets the ci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be61cc07979f7f17054248acd3eadf67
http://europepmc.org/articles/PMC4951032?pdf=render
http://europepmc.org/articles/PMC4951032?pdf=render
Autor:
Kent E. Kester, Joanne M. Lumsden, Laure Y. Juompan, Robert Schwenk, Lisa Rein, D. Gray Heppner, Urszula Krzych
Publikováno v:
Vaccine. 29:8847-8854
In a Phase 2a trial of the RTS,S/AS vaccine, we described significant association between protection against infection and vaccine-induced CD4 T cells. To determine whether processing of the circumsporozoite protein as a component of the RTS,S partic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3930529712fb98446b4cd76ebaf9b9c
https://doi.org/10.1016/j.vaccine.2011.09.098
https://doi.org/10.1016/j.vaccine.2011.09.098
Autor:
James F. Cummings, Birgitte Giersing, W. Ripley Ballou, David E. Lanar, Elissa Malkin, Christian F. Ockenhouse, Kathryn Tucker, Filip Dubovsky, V. Ann Stewart, Mark E. Polhemus, Robin K. Nielsen, Megan Dowler, Marie-Claude Dubois, D. Gray Heppner, Robert Schwenk, Joe Cohen, Jack Williams, Laure Y. Juompan, Collette J. Hillier, Christine Prosperi, Kent E. Kester, Lisa A. Ware, Douglas S. Walsh, In-Kyu Yoon, B. Ted Hall, Urszula Krzych, Michele D. Spring
Publikováno v:
Vaccine. 28:5135-5144
Plasmodium falciparum Liver Stage Antigen 1 (LSA-1) is a pre-erythrocytic stage antigen. Our LSA-1 vaccine candidate is a recombinant protein with full-length C- and N-terminal flanking domains and two of the 17 amino acid repeats from the central re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e10eb21d2d3990dda9655444fa522891
https://doi.org/10.1016/j.vaccine.2009.08.046
https://doi.org/10.1016/j.vaccine.2009.08.046
Autor:
Francois Villinger, Karen L. Hutchinson, Soumya Nidtha, Laure Y. Juompan, David C. Montefiori, Francis J. Novembre
Publikováno v:
AIDS Research and Human Retroviruses. 24:573-586
The mechanisms of resistance to AIDS development in HIV-1-infected chimpanzees have remained elusive. Unique among chimpanzees naturally or experimentally infected with HIV, several animals of the Yerkes cohort have progressed to clinical AIDS with s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4f7da46aa59485d6059cbf975c50371
https://doi.org/10.1089/aid.2007.0182
https://doi.org/10.1089/aid.2007.0182
Autor:
Laure Y. Juompan, Jianghui Zhang, Nicholas U. Raja, David H. Holman, Stephen B. Deitz, Danher Wang, Min Luo, Kevin R. Porter, John Y. Dong, Kanakatte Raviprakash
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 76:743-751
There are approximately 100 million new cases of dengue (DEN) virus infection each year. Infection can result in illness ranging from a mild fever to hemorrhaging, shock, or even death. There are four serotypes of dengue virus (DEN1-4), and immunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f2cb12bfc1ba09dbaf3e4b4591e6fa6
https://doi.org/10.4269/ajtmh.2007.76.743
https://doi.org/10.4269/ajtmh.2007.76.743
Autor:
Min Luo, Stephen B. Deitz, Michael Hevey, Laure Y. Juompan, Charles M. Trubey, Kevin M. Moore, Jan Woraratanadharm, Nicholas U. Raja, Hong Yu, Danher Wang, John Y. Dong, Benjamin M. Swain
Publikováno v:
Virology. 353(2):324-332
The Marburg virus (MARV), an African filovirus closely related to the Ebola virus, causes a deadly hemorrhagic fever in humans, with up to 90% mortality. Currently, treatment of disease is only supportive, and no vaccines are available to prevent spr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af5bff7293c7a1d2b1e9426ad5988089
Autor:
Charles M. Trubey, Nicholas U. Raja, Alan L. Schmaljohn, Benjamin M. Swain, William D. Pratt, Kevin M. Moore, Min Luo, Hong Yu, Danher Wang, David H. Holman, Jan Woraratanadharm, Laure Y. Juompan, John Y. Dong, Stephen B. Deitz
Publikováno v:
Vaccine. 24:2975-2986
Marburg virus (MARV) is an African filovirus that causes a deadly hemorrhagic fever in humans, with up to 90% mortality. Currently, there are no MARV vaccines or therapies approved for human use. We hypothesized that developing a vaccine that induces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b550553f7162f38aacc5a6981712c472
https://doi.org/10.1016/j.vaccine.2005.11.046
https://doi.org/10.1016/j.vaccine.2005.11.046
Autor:
Min Luo, Jan Woraratanadharm, John Y. Dong, Laure Y. Juompan, Stephen B. Deitz, Nicholas U. Raja, William D. Pratt, Kevin M. Moore, Hong Yu, Benjamin M. Swain, Danher Wang, Mary Kate Hart, Charles M. Trubey
Publikováno v:
Journal of Virology. 80:2738-2746
Ebola virus (EBOV) causes a severe hemorrhagic fever for which there are currently no vaccines or effective treatments. While lethal human outbreaks have so far been restricted to sub-Saharan Africa, the potential exploitation of EBOV as a biological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffc4b36ed1f159605ad165d18ace714a
https://doi.org/10.1128/jvi.80.6.2738-2746.2006
https://doi.org/10.1128/jvi.80.6.2738-2746.2006
Autor:
D. Gray Heppner, Marie-Claude Dubois, Jack Williams, Randall Reidler, Michele D. Spring, Urszula Krzych, Evelina Angov, Robert W. Sauerwein, Lorraine Soisson, Joe Cohen, Opokua Ofori-Anyinam, W. Ripley Ballou, Megan Dowler, Kent E. Kester, Lisa A. Ware, Carter L. Diggs, Elke S. Bergmann-Leitner, James F. Cummings, Christian F. Ockenhouse, V. Ann Stewart, Stacey Bittner, Elissa Malkin, Cornelus C. Hermsen, Mark G. Kortepeter, Ev Tierney, Carole A. Long, Sake J. de Vlas, Robin Nielsen, Meng Shi, Sheetij Dutta, Laure Y. Juompan, David E. Lanar, Kathryn Tucker
Publikováno v:
PLoS One (print), 4(4), 5254-5254. Public Library of Science
PLoS One, 4
PLoS One, 4, 4
PLoS ONE
PLoS ONE, Vol 4, Iss 4, p e5254 (2009)
PLoS One, 4
PLoS One, 4, 4
PLoS ONE
PLoS ONE, Vol 4, Iss 4, p e5254 (2009)
Contains fulltext : 79496.pdf (Publisher’s version ) (Open Access) BACKGROUND: This Phase 1/2a study evaluated the safety, immunogenicity, and efficacy of an experimental malaria vaccine comprised of the recombinant Plasmodium falciparum protein ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99acc657375a3f1f8878e418662ada54
https://pure.eur.nl/en/publications/c47d03a6-a04f-4227-879d-16713818918f
https://pure.eur.nl/en/publications/c47d03a6-a04f-4227-879d-16713818918f
Autor:
Nicholas U, Raja, David H, Holman, Danher, Wang, Kanakatte, Raviprakash, Laure Y, Juompan, Stephen B, Deitz, Min, Luo, Jianghui, Zhang, Kevin R, Porter, John Y, Dong
Publikováno v:
The American journal of tropical medicine and hygiene. 76(4)
There are approximately 100 million new cases of dengue (DEN) virus infection each year. Infection can result in illness ranging from a mild fever to hemorrhaging, shock, or even death. There are four serotypes of dengue virus (DEN1-4), and immunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7d0edefdef7cb62aaecc148da32a3d4e
https://pubmed.ncbi.nlm.nih.gov/17426182
https://pubmed.ncbi.nlm.nih.gov/17426182